U.S. gas prices expected to increase following Covid-related decline in 2020
A customer wearing a protective mask uses a plastic shopping bag to hold a fuel nozzle while refueling a vehicle at an Exxon Mobil Corp. gas station in Arlington, Virginia.
Andrew Harrer | Bloomberg | Getty Images
U.S. gas prices are expected to increase 27 cents per gallon on average this year following a steep decline in 2020 due to the coronavirus pandemic, according to fuel data company GasBuddy.
The price increase is expected to be driven by higher demand for gasoline as more Americans return to daily commuting but continue to drive instead of fly when traveling longer distances, Patrick De Haan, head of petroleum analysis at GasBuddy, told CNBC.
GasBuddy is forecasting U.S. gasoline spending this year to rise to $325.6 billion, up 16.3% from $280 billion in 2020 – the lowest spending since at least 2004. That includes all gasoline supplied to the U.S. market for consumers and commercial customers.
—Michael Wayland
Primary physician discusses how the new Covid strain affects vaccine rollout
Dr. Kavita Patel, a primary care physician and Brookings Institution Fellow, joined "Squawk Box" to discuss how the new Covid strain may affect the vaccine rollout.
—Melodie Warner
It's 'premature' to change authorized vaccines dosing and schedules, FDA says
Seniors, who are 65 and over, wait in line at the Department of Health Sarasota COVID-19 Vaccination Clinic in Sarasota, Florida, January 4, 2021.
Octavio Jones | Reuters
U.S. regulators said changing the authorized dosing or schedules of Covid-19 vaccines is premature and not supported by the data available, Reuters reports.
The U.S. Food and Drug Administration said, "At this time suggesting changes to the FDA-authorized dosing or schedules of these vaccines is premature and not rooted solidly in the available evidence."
The FDA said it had been watching reports about lowering the number of doses, extending the length of time between doses, cutting doses in half, or mixing and matching vaccines in order to immunize more people, Reuters said.
"Without appropriate data supporting such changes in vaccine administration, we run a significant risk of placing public health at risk," the FDA said in a statement.
—Terri Cullen
Manager of care home that vaccinated all residents discusses rollout process
Paul Johnston, Manager of the Palmerston Residential Care Home in Belfast, Northern Ireland, joined Worldwide Exchange to discuss his experience after getting the second dose of the vaccine. Johnston manages the first care home in the Western world to vaccinate all its residents.
—Melodie Warner
UK's decision to delay second vaccine proves controversial
The U.K.'s decision to delay administration of the second coronavirus vaccine dose is proving controversial with experts, advisors and the vaccine producers all weighing in on the plan.
Britain was among the first countries to kick off a mass vaccination campaign after approving the Covid-19 vaccine developed by Pfizer and BioNTech at the start of December. On Monday, it started rolling out the University of Oxford and AstraZeneca vaccine. Both vaccines require two doses per person.
While the U.K. government initially said that the second dose would be given to people either three or four weeks after the first dose, in line with the dosing regimens tested in clinical trials, it is now recommending a gap of up to 12 weeks.
The move is an effort to give more people a first dose – and some initial protection against Covid-19 – amid a surge in infections, largely attributed to a new strain of the virus that has become prevalent in parts of England.
—Holly Ellyatt
Read CNBC’s previous live coverage here:
https://ift.tt/3rW0OYZ
Business
No comments:
Post a Comment